000 | 01313 a2200361 4500 | ||
---|---|---|---|
005 | 20250515150541.0 | ||
264 | 0 | _c20081218 | |
008 | 200812s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/01.wnl.0000335938.26633.e7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBönnemann, Carsten G | |
245 | 0 | 0 |
_aLinking SMN to SMA: an assay for the rescuer. _h[electronic resource] |
260 |
_bNeurology _cNov 2008 |
||
300 |
_a1752-3 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCentral Nervous System Agents _xtherapeutic use |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxyurea _xtherapeutic use |
650 | 0 | 4 |
_aMotor Neurons _xdrug effects |
650 | 0 | 4 |
_aMuscular Atrophy, Spinal _xblood |
650 | 0 | 4 |
_aPhenylbutyrates _xtherapeutic use |
650 | 0 | 4 |
_aProtein Splicing _xgenetics |
650 | 0 | 4 | _aResearch Support as Topic |
650 | 0 | 4 |
_aSurvival of Motor Neuron 1 Protein _xblood |
650 | 0 | 4 | _aTranscription, Genetic |
650 | 0 | 4 |
_aValproic Acid _xtherapeutic use |
700 | 1 | _aFinkel, Richard S | |
773 | 0 |
_tNeurology _gvol. 71 _gno. 22 _gp. 1752-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000335938.26633.e7 _zAvailable from publisher's website |
999 |
_c18485661 _d18485661 |